WASHINGTON, Feb 28 – RIA Novosti. The US medical regulator, the FDA, has approved Johnson & Johnson's COVID-19 vaccine for “emergency” use, the regulator said in a statement.
Three coronavirus vaccines will now be used in the United States, two others from Pfizer and Moderna.
The vaccine is manufactured by Janssen Pharmaceutica, a division of Johnson & Johnson. Unlike the vaccines already approved in the USA, this vaccine is a vector vaccine, similar to the Russian “Sputnik V” and the Anglo-Swedish AstraZeneca. The vaccine uses the common cold virus and targets the spike protein on the surface of the virus. Unlike other US-approved vaccines, this one requires only one injection, not two.
Johnson & Johnson expects to deliver up to 20 million doses of the vaccine by the end of March and up to 100 million doses by the end of June.